世界のハイスループットスクリーニング(HTS)市場(~2025年):製品別(機器、ソフトウェア、サービス)、技術別(細胞系アッセイ、ラベルフリー)、用途別(創薬、生化学的スクリーニング、研究)、エンドユーザー別(製薬・バイオテクノロジー、CRO)

◆英語タイトル:High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025
◆商品コード:BT2220
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月26日
◆ページ数:304
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥569,250見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥764,750見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥937,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界のハイスループットスクリーニング(HTS)市場規模が2020年153億ドルから2025年264億ドルまで、年平均11.5%成長すると予測しています。本調査レポートでは、ハイスループットスクリーニング(HTS)の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(消耗品、器具、サービス、ソフトウェア)分析、技術別(細胞系アッセイ、ラボオンチップ、ラベルフリー)分析、用途別(創薬、生化学的スクリーニング、ライフサイエンス研究、その他)分析、エンドユーザー別(製薬・バイオテクノロジー、学術・研究機関、CRO、その他)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・ハイスループットスクリーニング(HTS)の世界市場規模:製品・サービス別(消耗品、器具、サービス、ソフトウェア)
・ハイスループットスクリーニング(HTS)の世界市場規模:技術別(細胞系アッセイ、ラボオンチップ、ラベルフリー)
・ハイスループットスクリーニング(HTS)の世界市場規模:用途別(創薬、生化学的スクリーニング、ライフサイエンス研究、その他)
・ハイスループットスクリーニング(HTS)の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー、学術・研究機関、CRO、その他)
・ハイスループットスクリーニング(HTS)の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global high-throughput screening market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.”
The growth in this market is primarily attributed to increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets are expected to provide growth opportunities for players operating in the high-throughput screening market in the coming years. However, costly and time-consuming nature of HTS techniques and a serious shortage of skilled operators in the industry are the major challenge in this market.

“The services segment accounted for the highest growth rate in the high-throughput screening market, by product & service, during the forecast period”
The high-throughput screening market is segmented into consumables, instruments, , services, and software. The services segment accounted for the highest growth rate in the high-throughput screening market in 2020. This segment’s large share can be attributed to large pharmaceutical companies routinely engaging in outsourcing many tasks such as screening and lead identification, toxicology, and other preclinical studies.

“Contract research organizations segment accounted for the highest CAGR”
Based on end user , the high-throughput screeningmarket is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs) and other end users. In 2020, contract research organizations accounted for the highest growth rate. The major factor driving the growth of this segment is increasing trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies.

“Label-free Technology segment accounted for the highest CAGR”
Based on technology , the high-throughput screeningmarket is segmented into cell-based assays, lab-on-a-chip technology, and label-free technology. In 2020, the label-free technology segment accounted for the highest growth rate. Label-free technology provides a simple assessment technique for studying complex biological pathways as it does not involve the use of labels. This will support the growth of this technology segment in the HTS market during forecast period.

“Drug Discovery segment accounted for the highest CAGR”
Based on application , the high-throughput screeningmarket is segmented into drug discovery, biochemical screening, life sciences research and other applications. In 2020, the drug discovery segment accounted for the highest growth rate. The key factor driving this segment’s growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

“Asia Pacific: The fastest-growing country in the high-throughput screening market”
The high-throughput screening market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 37%, Tier 2 – 22%, and Tier 3 – 41%
• By Designation: C-level – 25%, D-level – 20%, and Others – 55%
• By Region: North America -40%, Europe -27%, Asia-Pacific -20%, RoW -13%

Lists of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• PerkinElmer, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• AXXAM S.p.A (Italy)
• Promega Corporation (US)
• Bio-Rad Laboratories, Inc.(US)
• Promega Corporation (US)
• Hamilton Company (US)
• Corning Incorporated (US)
• Charles River Laboratories (US)
• Lonza (Switzerland)
• REPROCELL Inc. (Japan)
• Aurora Biomed (Canada)
• BMG LABTECH (Germany)
• DIANA Biotechnologies, s.r.o. (Czech Republic)
• NanoTemper Technologies GmbH (Germany)
• Creative Biolabs (US)
• Biomat Srl (Italy)

Research Coverage:
This report provides a detailed picture of the Immunofluorescence assay market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, type, disease, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall high-throughput screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

【レポートの目次】

1 INTRODUCTION 46
1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 47
1.2.1 INCLUSIONS & EXCLUSIONS 47
1.3 MARKET SCOPE 48
1.3.1 MARKETS COVERED 48
1.3.2 YEARS CONSIDERED IN THE REPORT 49
1.4 CURRENCY 49
1.5 STAKEHOLDERS 49
1.6 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH DATA 51
FIGURE 1 RESEARCH DESIGN 51
2.1.1 SECONDARY DATA 52
2.1.1.1 Key data from secondary sources 52
2.1.2 PRIMARY DATA 53
FIGURE 2 PRIMARY SOURCES 53
2.1.2.1 Key data from primary sources 54
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS 54
2.2 MARKET SIZE ESTIMATION 55
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 55
FIGURE 5 MARKET SIZE ESTIMATION: HIGH THROUGHPUT SCREENING MARKET 56
2.3 GROWTH RATE ASSUMPTIONS /GROWTH FORECAST 57
FIGURE 6 SEGMENTAL GROWTH RATE OF COMPANIES (2016−2019) 57
FIGURE 7 FINAL CAGR PROJECTIONS (2020−2025) 58
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES 58
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 59
FIGURE 9 DATA TRIANGULATION METHODOLOGY 59
2.5 MARKET SHARE ESTIMATION 60
2.6 ASSUMPTIONS FOR THE STUDY 60
3 EXECUTIVE SUMMARY 61
FIGURE 10 GLOBAL HTS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD BILLION) 61
FIGURE 11 GLOBAL HTS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD BILLION) 62
FIGURE 12 GLOBAL HTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION) 62
FIGURE 13 GLOBAL HTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 63
FIGURE 14 HTS MARKET: GEOGRAPHIC SNAPSHOT 64
4 PREMIUM INSIGHTS 65
4.1 HIGH-THROUGHPUT SCREENING MARKET OVERVIEW 65
FIGURE 15 INCREASING GOVERNMENT FUNDING FOR PHARMACEUTICAL R&D AND TECHNOLOGICAL ADVANCEMENTS IN THE HTS MARKET ARE KEY GROWTH DRIVERS 65
4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, MARKET SHARE (2019) 66
FIGURE 16 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN HIGH-THROUGHPUT SCREENING MARKET IN 2019 66
4.3 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 17 CHINA TO WITNESS THE HIGHEST GROWTH RATE IN THE HTS MARKET DURING THE FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 18 HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.2.1 MARKET DRIVERS 69
5.2.1.1 The growing adoption of open innovation models in pharmaceutical & biotechnology companies 69
5.2.1.2 Government funding and venture capital investments 69
5.2.1.3 Increasing R&D spending 70
TABLE 1 INCREASE IN COMPANY R&D EXPENDITURE (2018–2019) 70
5.2.1.4 Technological advancements in the HTS market 71
5.2.2 MARKET RESTRAINTS 71
5.2.2.1 The capital-intensive nature of HTS instruments 71
5.2.2.2 Complexities in assay development 72
5.2.3 MARKET OPPORTUNITIES 72
5.2.3.1 Emerging markets 72
5.2.3.2 Growing applications in stem cell research 73
5.2.4 MARKET CHALLENGES 73
5.2.4.1 The dearth of skilled operators 73
FIGURE 19 FUNCTIONAL AREAS WITH DIFFICULT TO FILL POSITIONS 74
5.3 IMPACT OF THE COVID-19 ON THE MARKET 74
5.3.1 COVID-19 VACCINE CANDIDATES: KEY DEVELOPMENTS 75
5.3.2 COVID-19 DRUG R&D: VACCINE PRODUCTION SCENARIO, BY COUNTRY 75
5.4 TECHNOLOGY ANALYSIS 76
5.4.1 LABEL-FREE TECHNOLOGY 76
5.4.2 AUTOMATION & MINIATURIZATION 77
5.4.3 MICROFLUIDICS 77
5.5 PRICING ANALYSIS 77
5.6 VALUE CHAIN ANALYSIS 78
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND
ASSEMBLY PHASE 78
5.7 SUPPLY CHAIN ANALYSIS 79
FIGURE 21 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 80
5.8 ECOSYSTEM ANALYSIS OF THE HTS MARKET 80
FIGURE 22 ECOSYSTEM ANALYSIS OF THE HTS MARKET 80
5.9 PORTER’S FIVE FORCES ANALYSIS 81
FIGURE 23 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS 81
5.9.1 THREAT OF NEW ENTRANTS 81
5.9.2 THREAT OF SUBSTITUTES 82
5.9.3 BARGAINING POWER OF BUYERS 82
5.9.4 BARGAINING POWER OF SUPPLIERS 82
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 82
5.10 REGULATORY ANALYSIS 82
5.11 PATENT ANALYSIS 84
FIGURE 24 NO OF PATENT GRANTED FOR HIGH THROUGHPUT SCREENING METHOD DEVELOPMENT, JANUARY 2010 – DECEMBER 2020 84
6 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE 85
6.1 INTRODUCTION 86
TABLE 2 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 86
6.2 CONSUMABLES 86
TABLE 3 HTS CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 87
TABLE 4 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 87
TABLE 5 EUROPE: CONSUMABLES MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 87
TABLE 6 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 88
TABLE 7 ROW: CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 88
TABLE 8 HTS CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 88
6.2.1 REAGENTS & ASSAY KITS 89
6.2.1.1 Reagents & assay kits accounted for the largest share of the consumables segment in 2019 89
TABLE 9 REAGENTS & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 89
TABLE 10 NORTH AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 89
TABLE 11 EUROPE: REAGENTS & ASSAY KITS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 90
TABLE 12 ASIA PACIFIC: REAGENTS & ASSAY KITS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 90
TABLE 13 ROW: REAGENTS & ASSAY KITS MARKET, BY REGION,
2018–2025 (USD MILLION) 90
6.2.2 LABORATORY EQUIPMENT 91
6.2.2.1 The development of high-quality equipment by market players will propel market growth 91
TABLE 14 LABORATORY EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION) 91
TABLE 15 NORTH AMERICA: LABORATORY EQUIPMENT MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 91
TABLE 16 EUROPE: LABORATORY EQUIPMENT MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 92
TABLE 17 ASIA PACIFIC: LABORATORY EQUIPMENT MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 92
TABLE 18 ROW: LABORATORY EQUIPMENT MARKET, BY REGION,
2018–2025 (USD MILLION) 92
6.3 INSTRUMENTS 93
TABLE 19 HTS INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 93
TABLE 20 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 93
TABLE 21 EUROPE: INSTRUMENTS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 94
TABLE 22 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 94
TABLE 23 ROW: INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 94
TABLE 24 HTS INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 95
6.3.1 LIQUID HANDLING SYSTEMS 95
6.3.1.1 The liquid handling systems segment is projected to witness the highest growth rate during the forecast period 95
TABLE 25 LIQUID HANDLING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 95
TABLE 26 NORTH AMERICA: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 27 EUROPE: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 96
TABLE 28 ASIA PACIFIC: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 96
TABLE 29 ROW: LIQUID HANDLING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 97
6.3.2 DETECTION SYSTEMS 97
6.3.2.1 Growth in this segment can be attributed to technological advancements in automation 97
TABLE 30 DETECTION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 97
TABLE 31 NORTH AMERICA: DETECTION SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 98
TABLE 32 EUROPE: DETECTION SYSTEMS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 98
TABLE 33 ASIA PACIFIC: DETECTION SYSTEMS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 98
TABLE 34 ROW: DETECTION SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 99
6.3.3 OTHER INSTRUMENTS 99
TABLE 35 OTHER INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 99
TABLE 36 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 99
TABLE 37 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 100
TABLE 38 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 100
TABLE 39 ROW: OTHER INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 100
6.4 SERVICES 101
6.4.1 THIS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR DUE TO THE INCREASING OUTSOURCING OF R&D ACTIVITIES IN EMERGING MARKETS 101
TABLE 40 HTS SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 101
TABLE 41 NORTH AMERICA: SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
TABLE 42 EUROPE: SERVICES MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 102
TABLE 43 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 102
TABLE 44 ROW: SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 102
6.5 SOFTWARE 103
6.5.1 AUTOMATION IN HTS AND THE AVAILABILITY OF ROBUST DATA MANAGEMENT SOFTWARE TOOLS TO DRIVE MARKET GROWTH 103
TABLE 45 HTS SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION) 103
TABLE 46 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 103
TABLE 47 EUROPE: SOFTWARE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 104
TABLE 48 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 104
TABLE 49 ROW: SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION) 104
7 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY 105
7.1 INTRODUCTION 106
TABLE 50 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 106
7.2 CELL-BASED ASSAYS 106
TABLE 51 HTS FOR CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 52 CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION) 107
TABLE 53 NORTH AMERICA: CELL- BASED ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 107
TABLE 54 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 108
TABLE 55 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 108
TABLE 56 ROW: CELL-BASED ASSAYS MARKET, BY REGION,
2018–2025 (USD MILLION) 108
7.2.1 2D CELL CULTURE 109
7.2.1.1 Market growth can be attributed to the cost-effectiveness of 2D cell culture systems 109
TABLE 57 2D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION) 109
TABLE 58 NORTH AMERICA: 2D CELL CULTURE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 109
TABLE 59 EUROPE: 2D CELL CULTURE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 110
TABLE 60 ASIA PACIFIC: 2D CELL CULTURE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 110
TABLE 61 ROW: 2D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION) 110
7.2.2 3D CELL CULTURE 111
TABLE 62 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 63 3D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION) 111
TABLE 64 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 112
TABLE 65 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 112
TABLE 66 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 112
TABLE 67 ROW: 3D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION) 113
7.2.2.1 Scaffold-based technology 113
TABLE 68 SCAFFOLD-BASED TECHNOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
TABLE 69 SCAFFOLD-BASED TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 114
TABLE 70 NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 114
TABLE 71 EUROPE: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 114
TABLE 72 ASIA PACIFIC: SCAFFOLD-BASED TECHNOLOGY MARKET,
BY COUNTRY/REGION, 2018–2025 (USD MILLION) 115
TABLE 73 ROW: SCAFFOLD-BASED TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 115
7.2.2.1.1 Hydrogels 115
TABLE 74 HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 75 HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION) 116
TABLE 76 NORTH AMERICA: HYDROGELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 116
TABLE 77 EUROPE: HYDROGELS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 117
TABLE 78 ASIA PACIFIC: HYDROGELS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 117
TABLE 79 ROW: HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION) 117
7.2.2.1.1.1 Animal-derived hydrogels 118
TABLE 80 ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2020–2025 (USD MILLION) 118
TABLE 81 ANIMAL-DERIVED HYDROGELS MARKET, BY REGION,
2018–2025 (USD MILLION) 118
TABLE 82 NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 118
TABLE 83 EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 119
TABLE 84 ASIA PACIFIC: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 119
TABLE 85 ROW: ANIMAL-DERIVED HYDROGELS MARKET, BY REGION,
2018–2025 (USD MILLION) 119
7.2.2.1.1.1.1 Matrigel 120
7.2.2.1.1.1.1.1 The Matrigel segment accounted for the largest share of the animal-derived hydrogels market in 2019 120
TABLE 86 MATRIGEL MARKET, BY REGION, 2018–2025 (USD MILLION) 120
TABLE 87 NORTH AMERICA: MATRIGEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 120
TABLE 88 EUROPE: MATRIGEL MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 121
TABLE 89 ASIA PACIFIC: MATRIGEL MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 121
TABLE 90 ROW: MATRIGEL MARKET, BY REGION, 2018–2025 (USD MILLION) 121
7.2.2.1.1.1.2 Collagen 122
TABLE 91 COLLAGEN MARKET, BY REGION, 2018–2025 (USD MILLION) 122
TABLE 92 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 122
TABLE 93 EUROPE: COLLAGEN MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 123
TABLE 94 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 123
TABLE 95 ROW: COLLAGEN MARKET, BY REGION, 2018–2025 (USD MILLION) 123
7.2.2.1.1.2 Synthetic hydrogels 124
7.2.2.1.1.2.1 The long service life and high gel strength of synthetic hydrogels drive the market growth 124
TABLE 96 SYNTHETIC HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION) 124
TABLE 97 NORTH AMERICA: SYNTHETIC HYDROGELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 124
TABLE 98 EUROPE: SYNTHETIC HYDROGELS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 125
TABLE 99 ASIA PACIFIC: SYNTHETIC HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 125
TABLE 100 ROW: SYNTHETIC HYDROGELS MARKET, BY REGION,
2018–2025 (USD MILLION) 125
7.2.2.1.1.3 Alginate/Agarose 126
7.2.2.1.1.3.1 This technique is used to culture cells in soft agar gels from plant sources like algae 126
TABLE 101 ALGINATE/AGAROSE MARKET, BY REGION, 2018–2025 (USD MILLION) 126
TABLE 102 NORTH AMERICA: ALGINATE/AGAROSE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 126
TABLE 103 EUROPE: ALGINATE/AGAROSE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 127
TABLE 104 ASIA PACIFIC: ALGINATE/AGAROSE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 127
TABLE 105 ROW: ALGINATE/AGAROSE MARKET, BY REGION,
2018–2025 (USD MILLION) 127
7.2.2.1.2 Inert matrix/Solid scaffolds 128
7.2.2.1.2.1 This technique minimizes batch-to-batch variation and promotes better reproducibility & consistency to the cell culture 128
TABLE 106 INERT MATRIX/SOLID SCAFFOLDS MARKET, BY REGION,
2018–2025 (USD MILLION) 128
TABLE 107 NORTH AMERICA: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 128
TABLE 108 EUROPE: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 129
TABLE 109 ASIA PACIFIC: INERT MATRIX/SOLID SCAFFOLDS MARKET,
BY COUNTRY/REGION, 2018–2025 (USD MILLION) 129
TABLE 110 ROW: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY REGION,
2018–2025 (USD MILLION) 129
7.2.2.1.3 Micropatterned surfaces 130
7.2.2.1.3.1 Micropatterned surfaces enhance the expression of enzymes levels and drug reactivity in cell cultures 130
TABLE 111 MICROPATTERNED SURFACES MARKET, BY REGION,
2018–2025 (USD MILLION) 130
TABLE 112 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 130
TABLE 113 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 131
TABLE 114 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET,
BY COUNTRY/REGION, 2018–2025 (USD MILLION) 131
TABLE 115 ROW: MICROPATTERNED SURFACES MARKET, BY REGION,
2018–2025 (USD MILLION) 131
7.2.2.2 Scaffold-free technology 132
TABLE 116 SCAFFOLD-FREE TECHNOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 117 SCAFFOLD-FREE TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 132
TABLE 118 NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 132
TABLE 119 EUROPE: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 133
TABLE 120 ASIA PACIFIC: SCAFFOLD-FREE TECHNOLOGY MARKET,
BY COUNTRY/REGION, 2018–2025 (USD MILLION) 133
TABLE 121 ROW: SCAFFOLD-FREE TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 133
7.2.2.2.1 Ultra-low binding plates 134
7.2.2.2.1.1 This segment accounted for the largest share of the scaffold-free technology market in 2019 134
TABLE 122 ULTRA-LOW BINDING PLATES MARKET, BY REGION,
2018–2025 (USD MILLION) 134
TABLE 123 NORTH AMERICA: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 135
TABLE 124 EUROPE: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 135
TABLE 125 ASIA PACIFIC: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 135
TABLE 126 ROW: ULTRA-LOW BINDING PLATES MARKET, BY REGION,
2018–2025 (USD MILLION) 136
7.2.2.2.2 Hanging-drop plates 136
7.2.2.2.2.1 The cost-effectiveness of hanging-drop plates over other methods for 3D cell culture drives the market growth 136
TABLE 127 HANGING-DROP PLATES MARKET, BY REGION, 2018–2025 (USD MILLION) 136
TABLE 128 NORTH AMERICA: HANGING-DROP PLATES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 137
TABLE 129 EUROPE: HANGING-DROP PLATES MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 137
TABLE 130 ASIA PACIFIC: HANGING-DROP PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 137
TABLE 131 ROW: HANGING-DROP PLATES MARKET, BY REGION,
2018–2025 (USD MILLION) 138
7.2.2.2.3 Other scaffold-free technologies 138
TABLE 132 OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 139
TABLE 133 NORTH AMERICA: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 139
TABLE 134 EUROPE: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET,
BY COUNTRY/REGION, 2018–2025 (USD MILLION) 139
TABLE 135 ASIA PACIFIC: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET,
BY COUNTRY/REGION, 2018–2025 (USD MILLION) 140
TABLE 136 ROW: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 140
7.2.3 REPORTER-BASED ASSAYS 140
7.2.3.1 Growing applications of gene expression will support the market growth of this segment 140
TABLE 137 REPORTER-BASED ASSAYS MARKET, BY REGION,
2018–2025 (USD MILLION) 141
TABLE 138 NORTH AMERICA: REPORTER-BASED ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 141
TABLE 139 EUROPE: REPORTER-BASED ASSAYS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 141
TABLE 140 ASIA PACIFIC: REPORTER-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 142
TABLE 141 ROW: REPORTER-BASED ASSAYS MARKET, BY REGION,
2018–2025 (USD MILLION) 142
7.2.4 PERFUSION CELL CULTURE 142
7.2.4.1 Perfusion cell culture provides higher product output as compared to traditional techniques 142
TABLE 142 PERFUSION CELL CULTURE MARKET, BY REGION,
2018–2025 (USD MILLION) 143
TABLE 143 NORTH AMERICA: PERFUSION CELL CULTURE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 143
TABLE 144 EUROPE: PERFUSION CELL CULTURE MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 143
TABLE 145 ASIA PACIFIC: PERFUSION CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 144
TABLE 146 ROW: PERFUSION CELL CULTURE MARKET, BY REGION,
2018–2025 (USD MILLION) 144
7.3 LAB-ON-A-CHIP TECHNOLOGY (LOC) 144
7.3.1 MARKET GROWTH CAN BE ATTRIBUTED TO COST-EFFECTIVENESS OF THE TECHNIQUE OWING TO THE LOW CONSUMPTION OF REAGENTS 144
TABLE 147 HTS FOR LAB-ON-A-CHIP TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 145
TABLE 148 NORTH AMERICA: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 145
TABLE 149 EUROPE: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 145
TABLE 150 ASIA PACIFIC: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 146
TABLE 151 ROW: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 146
7.4 LABEL-FREE TECHNOLOGY 146
7.4.1 LABEL-FREE TECHNOLOGY ENABLES THE INVESTIGATION OF BIOMOLECULAR INTERACTIONS WITHOUT THE EFFECTS OF LABELS 146
TABLE 152 HTS FOR LABEL-FREE TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 147
TABLE 153 NORTH AMERICA: LABEL-FREE TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 147
TABLE 154 EUROPE: LABEL-FREE TECHNOLOGY, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 147
TABLE 155 ASIA PACIFIC: LABEL-FREE TECHNOLOGY, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 148
TABLE 156 ROW: LABEL-FREE TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION) 148
8 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION 149
8.1 INTRODUCTION 150
TABLE 157 GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 150
8.2 DRUG DISCOVERY 150
8.2.1 INCREASING DEMAND FOR DRUGS IN THE TREATMENT OF VARIOUS DISEASES TO DRIVE MARKET GROWTH 150
TABLE 158 DRUG DISCOVERY MARKET, BY REGION, 2018–2025 (USD MILLION) 151
TABLE 159 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 151
TABLE 160 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 151
TABLE 161 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 152
TABLE 162 ROW: DRUG DISCOVERY MARKET, BY REGION, 2018–2025 (USD MILLION) 152
8.3 BIOCHEMICAL SCREENING 152
8.3.1 THE INCREASING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO DRIVE MARKET GROWTH 152
TABLE 163 BIOCHEMICAL SCREENING MARKET, BY REGION,
2018–2025 (USD MILLION) 153
TABLE 164 NORTH AMERICA: BIOCHEMICAL SCREENING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 153
TABLE 165 EUROPE: BIOCHEMICAL SCREENING MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 153
TABLE 166 ASIA PACIFIC: BIOCHEMICAL SCREENING MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 154
TABLE 167 ROW: BIOCHEMICAL SCREENING MARKET, BY REGION,
2018–2025 (USD MILLION) 154
8.4 LIFE SCIENCES RESEARCH 154
8.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH & THE STUDY OF INFECTIOUS DISEASES TO CONTRIBUTE TO MARKET GROWTH 154
TABLE 168 LIFE SCIENCES RESEARCH MARKET, BY REGION, 2018–2025 (USD MILLION) 155
TABLE 169 NORTH AMERICA: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 155
TABLE 170 EUROPE: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 155
TABLE 171 ASIA PACIFIC: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 156
TABLE 172 ROW: LIFE SCIENCES RESEARCH MARKET, BY REGION,
2018–2025 (USD MILLION) 156
8.5 OTHER APPLICATIONS 156
TABLE 173 OTHER APPLICATIONS MARKET, BY REGION, 2018–2025 (USD MILLION) 157
TABLE 174 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 157
TABLE 175 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 157
TABLE 176 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION,
2018–2025 (USD MILLION) 158
TABLE 177 ROW: OTHER APPLICATIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 158
9 HIGH-THROUGHPUT SCREENING MARKET, BY END USER 159
9.1 INTRODUCTION 160
TABLE 178 HIGH-THROUGHPUT SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 160
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 160
9.2.1 RISING R&D SPENDING BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH 160
TABLE 179 HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY REGION, 2018-2025 (USD MILLION) 161
TABLE 180 NORTH AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 161
TABLE 181 EUROPE: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2018-2025 (USD MILLION) 161
TABLE 182 ASIA PACIFIC: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2018-2025 (USD MILLION) 162
TABLE 183 ROW: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION) 162

9.3 ACADEMIC & RESEARCH INSTITUTES 162
9.3.1 COLLABORATIONS BETWEEN PHARMACEUTICAL COMPANIES AND RESEARCHERS TO CONTRIBUTE TO THE GROWTH OF THIS MARKET 162
TABLE 184 HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,
2018–2025 (USD MILLION) 163
TABLE 185 NORTH AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2018-2025 (USD MILLION) 163
TABLE 186 EUROPE: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY/REGION, 2018-2025 (USD MILLION) 164
TABLE 187 ASIA PACIFIC: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY/REGION, 2018-2025 (USD MILLION) 164
TABLE 188 ROW: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION) 164
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 165
9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS 165
TABLE 189 HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 165
TABLE 190 NORTH AMERICA: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION) 165
TABLE 191 EUROPE: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY COUNTRY/REGION, 2018-2025 (USD MILLION) 166
TABLE 192 ASIA PACIFIC: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY COUNTRY/REGION, 2018-2025 (USD MILLION) 166
TABLE 193 ROW: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION) 166
9.5 OTHER END USERS 167
TABLE 194 HTS MARKET FOR OTHER END USERS, BY REGION,
2018–2025 (USD MILLION) 167
TABLE 195 NORTH AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY,
2018-2025 (USD MILLION) 167
TABLE 196 EUROPE: HTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2018-2025 (USD MILLION) 168
TABLE 197 ASIA PACIFIC: HTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2018-2025 (USD MILLION) 168
TABLE 198 ROW: HTS MARKET FOR OTHER END USERS, BY REGION,
2018-2025 (USD MILLION) 168

10 HIGH-THROUGHPUT SCREENING MARKET, BY REGION 169
10.1 INTRODUCTION 170
TABLE 199 HTS MARKET, BY REGION, 2018–2025 (USD MILLION) 170
10.2 NORTH AMERICA 170
FIGURE 25 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT 171
TABLE 200 NORTH AMERICA: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 172
TABLE 201 NORTH AMERICA: HTS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 172
TABLE 202 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 172
TABLE 203 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE,
2018–2025 (USD MILLION) 173
TABLE 204 NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 205 NORTH AMERICA: HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 173
TABLE 206 NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 174
TABLE 207 NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 174
TABLE 208 NORTH AMERICA: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 174
TABLE 209 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 175
TABLE 210 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 175
TABLE 211 NORTH AMERICA: HTS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 175
TABLE 212 NORTH AMERICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 176
10.2.1 US 176
10.2.1.1 Market growth is attributed to rising government funding for research activities in the US 176
TABLE 213 NIH BUDGET FOR VARIOUS DISCIPLINES IN 2019 AND 2020 176
TABLE 214 US: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 177
TABLE 215 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 177
TABLE 216 US: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 178
TABLE 217 US: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 178
TABLE 218 US: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 178
TABLE 219 US: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 179
TABLE 220 US: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 179
TABLE 221 US: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION) 179
TABLE 222 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 180
TABLE 223 US: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 180
TABLE 224 US: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 180
TABLE 225 US: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 181
10.2.2 CANADA 181
10.2.2.1 Government funding to promote drug discovery will support market growth in Canada 181
TABLE 226 CANADA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 181
TABLE 227 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 182
TABLE 228 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 182
TABLE 229 CANADA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 182
TABLE 230 CANADA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 183
TABLE 231 CANADA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 183
TABLE 232 CANADA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 183
TABLE 233 CANADA: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 184
TABLE 234 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 184
TABLE 235 CANADA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 184
TABLE 236 CANADA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 185
TABLE 237 CANADA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 185
10.2.3 EUROPE 185
TABLE 238 EUROPE: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 186
TABLE 239 EUROPE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 186
TABLE 240 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 186
TABLE 241 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 187
TABLE 242 EUROPE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 187
TABLE 243 EUROPE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 187
TABLE 244 EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 188
TABLE 245 EUROPE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 188
TABLE 246 EUROPE: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 188
TABLE 247 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 189
TABLE 248 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 189
TABLE 249 EUROPE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 189
TABLE 250 EUROPE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 190
10.2.4 GERMANY 190
10.2.4.1 Increasing research activities for HTS to drive market growth in Germany 190
TABLE 251 GERMANY: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 190
TABLE 252 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 191
TABLE 253 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 191
TABLE 254 GERMANY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 191
TABLE 255 GERMANY: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 192
TABLE 256 GERMANY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 192
TABLE 257 GERMANY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 192
TABLE 258 GERMANY: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 193
TABLE 259 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 193
TABLE 260 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 193
TABLE 261 GERMANY: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 194
TABLE 262 GERMANY: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 194
10.2.5 UK 194
10.2.5.1 Government funding for the domestic production of pharmaceutical products to drive market growth in the UK 194
TABLE 263 UK: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 195
TABLE 264 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 195
TABLE 265 UK: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 196
TABLE 266 UK: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 196
TABLE 267 UK: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 196
TABLE 268 UK: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 197
TABLE 269 UK: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 197
TABLE 270 UK: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION) 197
TABLE 271 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 198
TABLE 272 UK: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 198
TABLE 273 UK: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 198
TABLE 274 UK: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 199
10.2.6 FRANCE 199
10.2.6.1 The growing pharmaceutical industry in France will support market growth for HTS technologies 199
TABLE 275 FRANCE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 200
TABLE 276 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 200
TABLE 277 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 200
TABLE 278 FRANCE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 201
TABLE 279 FRANCE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 201
TABLE 280 FRANCE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 201
TABLE 281 FRANCE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 202
TABLE 282 FRANCE: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 202
TABLE 283 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 202
TABLE 284 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 203
TABLE 285 FRANCE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 203
TABLE 286 FRANCE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 203
10.2.7 ITALY 204
10.2.7.1 Growing industry-academia collaborations to drive market growth in Italy 204
TABLE 287 ITALY: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 204
TABLE 288 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 204
TABLE 289 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 205
TABLE 290 ITALY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 205
TABLE 291 ITALY: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 205
TABLE 292 ITALY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 206
TABLE 293 ITALY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 206
TABLE 294 ITALY: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION) 206
TABLE 295 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 207
TABLE 296 ITALY: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 207
TABLE 297 ITALY: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 207
TABLE 298 ITALY: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 208
10.2.8 SPAIN 208
10.2.8.1 A nationwide research network supported by funding for various programs will drive market growth in Spain 208
TABLE 299 SPAIN: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 209
TABLE 300 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 209
TABLE 301 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 209
TABLE 302 SPAIN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 210
TABLE 303 SPAIN: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 210
TABLE 304 SPAIN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 210
TABLE 305 SPAIN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 211
TABLE 306 SPAIN: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 211
TABLE 307 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 211
TABLE 308 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 212
TABLE 309 SPAIN: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 212
TABLE 310 SPAIN: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 212
10.2.9 REST OF EUROPE 213
TABLE 311 ROE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 213
TABLE 312 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 213
TABLE 313 ROE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 214
TABLE 314 ROE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 214
TABLE 315 ROE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 214
TABLE 316 ROE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 215
TABLE 317 ROE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 215
TABLE 318 ROE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION) 215
TABLE 319 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 216
TABLE 320 ROE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 216
TABLE 321 ROE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 216
TABLE 322 ROE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 217
10.3 ASIA PACIFIC 217
FIGURE 26 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT 218
TABLE 323 ASIA PACIFIC: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 219
TABLE 324 ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 219
TABLE 325 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 219
TABLE 326 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE,
2018–2025 (USD MILLION) 220
TABLE 327 ASIA PACIFIC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 220
TABLE 328 ASIA PACIFIC: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 220
TABLE 329 ASIA PACIFIC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 221
TABLE 330 ASIA PACIFIC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 221
TABLE 331 ASIA PACIFIC: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 221
TABLE 332 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 222
TABLE 333 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 222
TABLE 334 ASIA PACIFIC: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 222
TABLE 335 ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 223
10.3.1 CHINA 223
10.3.1.1 The rising number of CROs in China supports market growth for HTS 223
TABLE 336 CHINA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 224
TABLE 337 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 224
TABLE 338 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 224
TABLE 339 CHINA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 225
TABLE 340 CHINA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 225
TABLE 341 CHINA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 225
TABLE 342 CHINA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 226
TABLE 343 CHINA: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 226
TABLE 344 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 226
TABLE 345 CHINA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 227
TABLE 346 CHINA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 227
TABLE 347 CHINA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 227
10.3.2 JAPAN 228
10.3.2.1 High R&D expenditure by pharmaceutical companies to drive market growth in Japan 228
TABLE 348 JAPAN: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 228
TABLE 349 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 229
TABLE 350 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 229
TABLE 351 JAPAN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 229
TABLE 352 JAPAN: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 230
TABLE 353 JAPAN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 230
TABLE 354 JAPAN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 230
TABLE 355 JAPAN: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 231
TABLE 356 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 231
TABLE 357 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 231
TABLE 358 JAPAN: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 232
TABLE 359 JAPAN: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 232
10.3.3 INDIA 232
10.3.3.1 Market growth can be attributed to increasing government funding for the Indian pharmaceutical industry 232
TABLE 360 INDIA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 233
TABLE 361 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 233
TABLE 362 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 233
TABLE 363 INDIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 234
TABLE 364 INDIA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 234
TABLE 365 INDIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 234
TABLE 366 INDIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 235
TABLE 367 INDIA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION) 235
TABLE 368 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 235
TABLE 369 INDIA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 236
TABLE 370 INDIA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 236
TABLE 371 INDIA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 236
10.3.4 AUSTRALIA 237
10.3.4.1 Collaborations between research centers and pharmaceutical companies for drug discovery will drive market growth in Australia 237
TABLE 372 AUSTRALIA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 237
TABLE 373 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 237
TABLE 374 AUSTRALIA: 3D CELL CULTURE MARKET, BY TYPE,
2018–2025 (USD MILLION) 238
TABLE 375 AUSTRALIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 238
TABLE 376 AUSTRALIA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 238
TABLE 377 AUSTRALIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 239
TABLE 378 AUSTRALIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 239
TABLE 379 AUSTRALIA: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 239
TABLE 380 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 240
TABLE 381 AUSTRALIA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 240
TABLE 382 AUSTRALIA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 240
TABLE 383 AUSTRALIA: HTS MARKET. BY END USER, 2018–2025 (USD MILLION) 241
10.3.5 REST OF THE ASIA PACIFIC (ROAPAC) 241
TABLE 384 ROAPAC: HTS MARKET. BY TECHNOLOGY, 2018–2025 (USD MILLION) 241
TABLE 385 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 242
TABLE 386 ROAPAC: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 242
TABLE 387 ROAPAC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 242
TABLE 388 ROAPAC: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 243
TABLE 389 ROAPAC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 243
TABLE 390 ROAPAC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 243
TABLE 391 ROAPAC: HTS MARKET. BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 244
TABLE 392 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 244
TABLE 393 ROAPAC: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 244
TABLE 394 ROAPAC: HTS MARKET. BY APPLICATION, 2018–2025 (USD MILLION) 245
TABLE 395 ROAPAC: HTS MARKET. BY END USER, 2018–2025 (USD MILLION) 245
10.4 REST OF THE WORLD (ROW) 245
TABLE 396 ROW: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 246
TABLE 397 ROW: HTS MARKET. BY TECHNOLOGY, 2018–2025 (USD MILLION) 246
TABLE 398 ROW: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 246
TABLE 399 ROW: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION) 247
TABLE 400 ROW: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 247
TABLE 401 ROW: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 247
TABLE 402 ROW: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 248
TABLE 403 ROW: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 248
TABLE 404 ROW: HTS MARKET. BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION) 248
TABLE 405 ROW: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 249
TABLE 406 ROW: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 249
TABLE 407 ROW: HTS MARKET. BY APPLICATION, 2018–2025 (USD MILLION) 249
TABLE 408 ROW: HTS MARKET. BY END USER, 2018–2025 (USD MILLION) 250
10.4.1 LATIN AMERICA 250
10.4.1.1 The emerging pharmaceutical industry in Latin America will drive market growth for HTS 250
TABLE 409 LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 250
TABLE 410 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 251
TABLE 411 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE,
2018–2025 (USD MILLION) 251
TABLE 412 LATIN AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 251
TABLE 413 LATIN AMERICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 252
TABLE 414 LATIN AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 252
TABLE 415 LATIN AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 252
TABLE 416 LATIN AMERICA: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 253
TABLE 417 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 253
TABLE 418 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 253
TABLE 419 LATIN AMERICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 254
TABLE 420 LATIN AMERICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION) 254
10.4.2 MIDDLE EAST AND AFRICA 254
10.4.2.1 Market growth can be attributed to changing demographics and favorable government policies for pharmaceutical R&D 254
TABLE 421 MIDDLE EAST AND AFRICA: HTS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 255
TABLE 422 MIDDLE EAST AND AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 255
TABLE 423 MIDDLE EAST AND AFRICA: 3D CELL CULTURE MARKET, BY TYPE,
2018–2025 (USD MILLION) 255
TABLE 424 MIDDLE EAST AND AFRICA: SCAFFOLD-BASED TECHNOLOGIES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 256
TABLE 425 MIDDLE EAST AND AFRICA: HYDROGELS MARKET, BY TYPE,
2018–2025 (USD MILLION) 256
TABLE 426 MIDDLE EAST AND AFRICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION) 256
TABLE 427 MIDDLE EAST AND AFRICA: SCAFFOLD-FREE TECHNOLOGIES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 257
TABLE 428 MIDDLE EAST AND AFRICA: HTS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 257
TABLE 429 MIDDLE EAST AND AFRICA: HTS MARKET, BY PRODUCT AND SERVICE,
2018–2025 (USD MILLION) 257
TABLE 430 MIDDLE EAST AND AFRICA: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 258
TABLE 431 MIDDLE EAST AND AFRICA: INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 258
TABLE 432 MIDDLE EAST AND AFRICA: HTS MARKET, BY END USER,
2018–2025 (USD MILLION) 258
11 COMPETITIVE LANDSCAPE 259
11.1 OVERVIEW 259
FIGURE 27 MARKET EVALUATION FRAMEWORK 259
11.2 REVENUE ANALYSIS OF TOP MARKET PLAYERS 260
TABLE 433 MARKET SHARE ANALYSIS: 2019 260
11.3 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION QUADRANT, 2019 261
11.3.1 STARS 261
11.3.2 EMERGING LEADERS 261
11.3.3 PERVASIVE COMPANIES 261
11.3.4 EMERGING COMPANIES 261
FIGURE 28 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX, 2019 262
11.4 HIGH-THROUGHPUT SCREENING MARKET: START-UP/SME EVALUATION MATRIX, 2019 263
11.4.1 PROGRESSIVE COMPANIES 263
11.4.2 STARTING BLOCKS 263
11.4.3 RESPONSIVE COMPANIES 263
11.4.4 DYNAMIC COMPANIES 263
FIGURE 29 HIGH-THROUGHPUT SCREENING MARKET: STARTUP/SME EVALUATION MATRIX, 2019 264
11.5 KEY MARKET DEVELOPMENTS 265
11.5.1 KEY PRODUCT LAUNCHES 265
11.5.2 KEY ACQUISITIONS 265
11.5.3 KEY ALLIANCES, AGREEMENTS, AND COLLABORATIONS 266
11.5.4 KEY EXPANSIONS 266

12 COMPANY PROFILES 267
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 THERMO FISHER SCIENTIFIC INC. 267
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019) 267
12.2 AGILENT TECHNOLOGIES, INC. 271
FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019) 271
12.3 MERCK KGAA 276
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019) 276
12.4 DANAHER CORPORATION 279
FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 279
12.5 PERKINELMER, INC. 282
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2019) 282
12.6 TECAN GROUP LTD. 286
FIGURE 35 TECAN GROUP LTD.: COMPANY SNAPSHOT (2019) 286
12.7 AXXAM S.P.A. 289
12.8 BIO-RAD LABORATORIES, INC. 291
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019) 291
12.9 PROMEGA CORPORATION 294
12.10 CORNING INCORPORATED 295
FIGURE 37 CORNING INCORPORATED: COMPANY SNAPSHOT (2019) 295
12.11 CHARLES RIVER LABORATORIES 297
FIGURE 38 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019) 297
12.12 EUROFINS SCIENTIFIC 299
FIGURE 39 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 299
12.13 HAMILTON COMPANY 301
12.14 LONZA 303
FIGURE 40 LONZA: COMPANY SNAPSHOT (2020) 303
12.15 REPROCELL INC. 304
12.16 AURORA BIOMED 306
12.17 BMG LABTECH 307
12.18 DIANA BIOTECHNOLOGIES S.R.O. 308
12.19 NANOTEMPER TECHNOLOGIES GMBH 308
12.20 CREATIVE BIOLABS 309
12.21 BIOMAT SRL 309
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 310
13.1 DISCUSSION GUIDE 310
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 316
13.3 AVAILABLE CUSTOMIZATIONS 318
13.4 RELATED REPORTS 318
13.5 AUTHOR DETAILS 319

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のハイスループットスクリーニング(HTS)市場(~2025年):製品別(機器、ソフトウェア、サービス)、技術別(細胞系アッセイ、ラベルフリー)、用途別(創薬、生化学的スクリーニング、研究)、エンドユーザー別(製薬・バイオテクノロジー、CRO)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆